Riskpilot← Back to searchSign inGet full accessFALCK HELSEFORMIDLING AS
ASActiveOrg 989930427Wergelandsveien 1, 0167 OsloOther human health activities n.e.c. · NACE 8699Est. 200655 employeeswww.falck.com
Revenue 2024
NOK 242,5M
+41% vs 2023
EBITDA margin
10.2%
-4% vs 2023
Equity ratio
14.6%
Financial strength
Net profit 2024
NOK 20M
+1% vs 2023
| Revenue | NOK 242,5M | +41% |
| EBITDA | NOK 24,8M | -4% |
| Net profit | NOK 20M | +1% |
| Total assets | NOK 110,5M | +51% |
| Equity | NOK 16,1M | -4% |
| Employees | 55 | — |
Legal name
FALCK HELSEFORMIDLING AS
Org number
989930427
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
17. juni 2006
Share capital
NOK 770 000
Employees
55 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Utøve virksomhet innen helsesektoren og tilhørende serviceområder, investere i norske virksomheter innenfor helsesektoren og tilhørende serviceområder og utøve virksomhet som etter styrets vurdering er naturlig tilknyttet dette.
Address
Wergelandsveien 1, 0167 Oslo
Website
www.falck.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 89 234 | 116 721 | 138 140 | 172 185 | 242 487 |
| Staff expenses | −26 286 | −28 024 | −27 978 | −22 634 | −29 670 |
| EBITDA | −7 478 | 8 368 | 10 065 | 25 756 | 24 824 |
| Depreciation & amort. | −4 059 | −669 | −513 | −232 | −4 |
| EBIT | −11 538 | 7 699 | 9 552 | 25 524 | 24 819 |
| Net financials | −2 100 | −1 098 | −926 | −213 | 871 |
| Profit before tax | −13 637 | 6 601 | 8 626 | 25 311 | 25 691 |
| Tax | −0 | −0 | −5 387 | 5 568 | 5 652 |
| Net profit | −13 637 | 6 601 | 14 013 | 19 743 | 20 039 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 63 522 | 86 224 | 54 724 | 73 318 | 110 546 |
| Equity | −13 414 | −6 813 | 12 507 | 16 750 | 16 133 |
| Long-term debt | 54 785 | 56 180 | 0 | 875 | 700 |
| Short-term debt | 22 151 | 36 857 | 42 218 | 55 693 | 93 713 |
| Total debt | 76 936 | 93 037 | 42 218 | 56 568 | 94 414 |
EBITDA margin
10.2%
This company
15.8%
Market median
-35% vs market
20202024
Equity ratio
14.6%
This company
38.2%
Market median
-62% vs market
20202024
Return on equity
124.2%
This company
18.4%
Market median
+575% vs market
20202024
Net profit margin
8.3%
This company
8.1%
Market median
+2% vs market
20202024
Asset turnover
2.19×
This company
1.12×
Market median
+96% vs market
20202024
Debt / equity
5.85×
This company
0.62×
Market median
-844% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
ME Deputy Member | Deputy Member | 2026 |
SE Chief Executive Officer | Chief Executive Officer | 2026 |
AR Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (3) | ||
PR Chief Executive Officer | Chief Executive Officer | 2019 – 2022 |
MH Chief Executive Officer | Chief Executive Officer | 2023 – 2025 |
HB Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2025 | |
| Chairman | 2026 | |
| Former (1) | ||
| Chairman | 2019 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Falck Healthcare As | Company | 100% | 100% | 2024 |
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of FALCK HELSEFORMIDLING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Rosnes Sinervo | Chief Executive Officer | 0 companies |
| Mads Espeløv Hansen | Deputy Member | 0 companies |
| Silje Eek Guttormsen | Chief Executive Officer | 0 companies |
| Anette Rasmussen | Chief Executive Officer | 0 companies |
| Martin Haakansson | Chief Executive Officer | 0 companies |
| Hilde Britt Skarbøvik Mellbye | Chief Executive Officer | 0 companies |
| Anette Elisabeth Falisse Damgaard | Chairman | 0 companies |
| Audun Borge Martinsen | Chairman | 0 companies |
| Johanna Maria Rastad | Chairman | 0 companies |